PayPal (NASDAQ: PYPL) shares surged in early Tuesday trading after the digital payments giant delivered stronger-than-expected third-quarter results and unveiled a strategic partnership with OpenAI, the creator of ChatGPT.
Mastercard's Pre-Earnings Reality Check: Buy, Sell or Hold Before Q3? — Positive
MA Zacks Investment Research — October 28, 2025MA prepares for its Q3 results with double-digit growth forecasts, rising costs and a premium valuation testing investor confidence.
STNE vs. UPST: Which Fintech Stock Should You Pick Now? — Positive
STNE UPST Zacks Investment Research — October 28, 2025StoneCo's steady profitability and disciplined growth outshine Upstart's volatile AI-driven lending surge, making it the stronger fintech contender now.
Should You Buy, Sell or Hold Chevron Stock Before Q3 Earnings? — Positive
CVX Zacks Investment Research — October 28, 2025As CVX gears up to report third-quarter earnings on Oct. 31, let's find out how the expectations stack up. Also. know how to play the stock ahead of results.
Should Lam Research Stock Be in Your Portfolio Post Solid Q1 Earnings? — Positive
LRCX Zacks Investment Research — October 28, 2025LRCX's strong Q1 earnings, AI-driven demand and attractive valuation make it a standout in the semiconductor space.
Hubbell (HUBB) Tops Q3 Earnings Estimates — Positive
HUBB Zacks Investment Research — October 28, 2025Hubbell (HUBB) came out with quarterly earnings of $5.17 per share, beating the Zacks Consensus Estimate of $4.99 per share. This compares to earnings of $4.49 per share a year ago.
HNI (HNI) came out with quarterly earnings of $1.1 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.03 per share a year ago.
NextEra Energy (NEE) Surpasses Q3 Earnings Estimates — Positive
NEE Zacks Investment Research — October 28, 2025NextEra Energy (NEE) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.03 per share a year ago.
Phinia (PHIN) Tops Q3 Earnings and Revenue Estimates — Positive
PHIN Zacks Investment Research — October 28, 2025Phinia (PHIN) came out with quarterly earnings of $1.59 per share, beating the Zacks Consensus Estimate of $1.17 per share. This compares to earnings of $1.17 per share a year ago.
Kiniksa Pharmaceuticals International, plc (KNSA) Q3 Earnings Miss Estimates — Negative
KNSA Zacks Investment Research — October 28, 2025Kiniksa Pharmaceuticals International, plc (KNSA) came out with quarterly earnings of $0.23 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to a loss of $0.18 per share a year ago.
Apple, Microsoft cross $4 trillion market cap for the first time — Positive
AAPL MSFT CNBC — October 28, 2025Apple passed a market cap of $4 trillion for the first time. Microsoft also reached the benchmark.
Takeaways From NextEra Energy (NEE) Q3 Earnings Beat — Positive
NEE 24/7 Wall Street — October 28, 2025NextEra beats EPS by 7.6%, reaffirming 2025 guidance and boosting 2026–2027 outlook amid strong cash flow.
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International — Neutral
BAX PRNewsWire — October 28, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Baxter between February 23, 2022 and July 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Oct. 28, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. ("Baxter" or the …
Will QCOM's New AI Inference Solutions Boost Growth Prospects? — Positive
QCOM Zacks Investment Research — October 28, 2025Qualcomm's new AI200 and AI250 cards promise powerful, efficient AI inference for next-gen data centers.
Olin's Earnings Top Estimates in Q3, Revenues Miss Amid Challenges — Negative
OLN Zacks Investment Research — October 28, 2025OLN posts solid Q3 profit rebound and higher revenues, though sales fell short of estimates amid market challenges.
Is CVS Health's Pharmacy & Consumer Wellness Poised for a Stronger Q3? — Positive
CVS Zacks Investment Research — October 28, 2025CVS' Pharmacy & Consumer Wellness arm gains traction from tech upgrades, new Rite Aid assets and its evolving CostVantage model.
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma — Neutral
ATYR PRNewsWire — October 28, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in aTyr between January 16, 2025 and September 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Oct. 28, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against aTyr Pharma, Inc. ("aTyr" or the …
Why I'm Downgrading AMD Ahead Of Earnings? (Preview) — Negative
AMD Seeking Alpha — October 28, 2025Advanced Micro Devices (AMD) is downgraded to 'Hold' ahead of Q3 earnings due to overvaluation and limited near-term upside. AMD's rally has shifted market sentiment from pessimism to extreme greed, with shares now priced close to perfection and risk of post-earnings correction. While AMD's business model shift and data center growth remain long-term positives, near-term risks include export restrictions and execution challenges.
Apple races past $4 trillion market value as latest models revitalize iPhone sales — Positive
AAPL Reuters — October 28, 2025Apple topped $4 trillion in market value for the first time on Tuesday, the third Big Tech company to hit the milestone, as robust demand for its latest iPhone models allayed fears over its slow progress in the AI race.
Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules — Neutral
CODX PRNewsWire — October 28, 2025SALT LAKE CITY , Oct. 28, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into a securities purchase agreement with several institutional investors for the purchase and sale of 12,727,272 shares of common stock (or pre-funded warrants in-lieu thereof) at an offering price of $0.55 per share, in a registered direct offering priced at-the-market under Nasdaq rules (the "Offering"). The gross proceeds to the Company from the Offering are estimated to be approximately $7.0 million …
